Novocure Ltd (NVCR)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $1.38B
Last updated: Nov 17, 2026 at 4:20 PM ET
Novocure Ltd (NVCR) Stock Chart
Novocure (NVCR) has a latest price of $11.14 on Nov 17, 2026, 48.1% below its 52-week high of $21.45. Its price fell 1.6% over the past 12 months. The month-end price rose 117.4% over the 10 years through Oct 2026, a compound annual rate of 8.1%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $221.82 in Jun 2021 and its lowest $6.05 in Oct 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart NVCR with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NVCR.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 38.8%, and over 6 months it fell 34.5%. The month-end price fell 1.1% over the 3 years through Oct 2026, a compound annual decline of 0.4%.
| Period | Change |
|---|---|
| 1 month | -25.2% |
| 3 months | -38.8% |
| 6 months | -34.5% |
| 12 months | -1.6% |
| 12 months, with dividends | -1.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -1.1% | -0.4% |
| 5 years | -87.2% | -33.7% |
| 10 years | +117.4% | +8.1% |
Price by Year
Its best calendar year was 2017, when the price rose 157.3%, and its weakest was 2023, when it fell 79.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $13.15 | +1.7% |
| 2025 | $12.93 | -56.6% |
| 2024 | $29.80 | +99.6% |
| 2023 | $14.93 | -79.6% |
| 2022 | $73.35 | -2.3% |
| 2021 | $75.08 | -56.6% |
| 2020 | $173.04 | +105.3% |
| 2019 | $84.27 | +151.7% |
| 2018 | $33.48 | +65.7% |
| 2017 | $20.20 | +157.3% |
Trading Range
The price is 23.6% below its 50-day average of $14.59 and 24.6% below its 200-day average of $14.78.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $11.14 | |
| 52-week high | $21.45 | -48.1% |
| 52-week low | $9.82 | +13.4% |
| 50-day average | $14.59 | -23.6% |
| 200-day average | $14.78 | -24.6% |
Price Risk
Over 3 years, its largest fall from a peak was 70.0%.
| Measure | Value |
|---|---|
| 1-year beta | 1.52 |
| Largest fall, 1 year | -44.3% |
| Largest fall, 3 years | -70.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About NVCR
What is NVCR's 1-year price change?
Novocure's price fell 1.6% over the past 12 months. With dividends included, the 12-month total return was -1.6%.
What is NVCR's 5-year price change?
Novocure's month-end price fell 87.2% over the 5 years through Oct 2026, a compound annual decline of 33.7%. These figures leave out dividends.
What is NVCR's 52-week high and low?
Novocure's 52-week high is $21.45 and its 52-week low is $9.82. Its latest price of $11.14 on Nov 17, 2026 is 48.1% below the high.
What is NVCR's beta?
Novocure's 1-year beta against the S&P 500 is 1.52, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 44.3%.
Is the NVCR chart free?
Yes. Advanced Charting for NVCR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
NVCR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts